136 related articles for article (PubMed ID: 11683531)
1. Effects of combination therapy with PTH and 17beta-estradiol on long bones of female mice.
Samuels A; Perry MJ; Gibson R; Tobias JH
Calcif Tissue Int; 2001 Sep; 69(3):164-70. PubMed ID: 11683531
[TBL] [Abstract][Full Text] [Related]
2. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.
Pierroz DD; Bouxsein ML; Rizzoli R; Ferrari SL
Bone; 2006 Aug; 39(2):260-7. PubMed ID: 16531131
[TBL] [Abstract][Full Text] [Related]
3. Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity.
Iida-Klein A; Lu SS; Cosman F; Lindsay R; Dempster DW
Bone; 2007 Feb; 40(2):391-8. PubMed ID: 17056311
[TBL] [Abstract][Full Text] [Related]
4. Differential transcriptional effects of PTH and estrogen during anabolic bone formation.
von Stechow D; Zurakowski D; Pettit AR; Müller R; Gronowicz G; Chorev M; Otu H; Libermann T; Alexander JM
J Cell Biochem; 2004 Oct; 93(3):476-90. PubMed ID: 15372627
[TBL] [Abstract][Full Text] [Related]
5. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
Iida-Klein A; Zhou H; Lu SS; Levine LR; Ducayen-Knowles M; Dempster DW; Nieves J; Lindsay R
J Bone Miner Res; 2002 May; 17(5):808-16. PubMed ID: 12009011
[TBL] [Abstract][Full Text] [Related]
6. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
Shen V; Birchman R; Wu DD; Lindsay R
J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
[TBL] [Abstract][Full Text] [Related]
7. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
Zhou H; Shen V; Dempster DW; Lindsay R
J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
[TBL] [Abstract][Full Text] [Related]
8. Maintenance of cortical bone in human parathyroid hormone(1-84)-treated ovariectomized rats.
Samnegård E; Iwaniec UT; Cullen DM; Kimmel DB; Recker RR
Bone; 2001 Mar; 28(3):251-60. PubMed ID: 11248654
[TBL] [Abstract][Full Text] [Related]
9. beta-Arrestin2 regulates the differential response of cortical and trabecular bone to intermittent PTH in female mice.
Bouxsein ML; Pierroz DD; Glatt V; Goddard DS; Cavat F; Rizzoli R; Ferrari SL
J Bone Miner Res; 2005 Apr; 20(4):635-43. PubMed ID: 15765183
[TBL] [Abstract][Full Text] [Related]
10. Bone anabolic effects of separate and combined therapy with growth hormone and parathyroid hormone on femoral neck in aged ovariectomized osteopenic rats.
Wang L; Orhii PB; Banu J; Kalu DN
Mech Ageing Dev; 2001 Jan; 122(1):89-104. PubMed ID: 11163626
[TBL] [Abstract][Full Text] [Related]
11. CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment.
Liu F; Lee SK; Adams DJ; Gronowicz GA; Kream BE
Bone; 2007 Apr; 40(4):1135-43. PubMed ID: 17275432
[TBL] [Abstract][Full Text] [Related]
12. Effects of low-dose parathyroid hormone on bone mass, turnover, and ectopic osteoinduction in a rat model for chronic alcohol abuse.
Iwaniec UT; Trevisiol CH; Maddalozzo GF; Rosen CJ; Turner RT
Bone; 2008 Apr; 42(4):695-701. PubMed ID: 18295560
[TBL] [Abstract][Full Text] [Related]
13. Differential temporal effects of sclerostin antibody and parathyroid hormone on cancellous and cortical bone and quantitative differences in effects on the osteoblast lineage in young intact rats.
Ominsky MS; Brown DL; Van G; Cordover D; Pacheco E; Frazier E; Cherepow L; Higgins-Garn M; Aguirre JI; Wronski TJ; Stolina M; Zhou L; Pyrah I; Boyce RW
Bone; 2015 Dec; 81():380-391. PubMed ID: 26261096
[TBL] [Abstract][Full Text] [Related]
14. Additional weight bearing during exercise and estrogen in the rat: the effect on bone mass, turnover, and structure.
Tromp AM; Bravenboer N; Tanck E; Oostlander A; Holzmann PJ; Kostense PJ; Roos JC; Burger EH; Huiskes R; Lips P
Calcif Tissue Int; 2006 Dec; 79(6):404-15. PubMed ID: 17160577
[TBL] [Abstract][Full Text] [Related]
15. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
[TBL] [Abstract][Full Text] [Related]
16. Effects of cyclic versus daily hPTH(1-34) regimens on bone strength in association with BMD, biochemical markers, and bone structure in mice.
Iida-Klein A; Hughes C; Lu SS; Moreno A; Shen V; Dempster DW; Cosman F; Lindsay R
J Bone Miner Res; 2006 Feb; 21(2):274-82. PubMed ID: 16418783
[TBL] [Abstract][Full Text] [Related]
17. Role of endothelial nitric oxide synthase in estrogen-induced osteogenesis.
Samuels A; Perry MJ; Gibson RL; Colley S; Tobias JH
Bone; 2001 Jul; 29(1):24-9. PubMed ID: 11472887
[TBL] [Abstract][Full Text] [Related]
18. Co-treatment of PTH with osteoprotegerin or alendronate increases its anabolic effect on the skeleton of oophorectomized mice.
Samadfam R; Xia Q; Goltzman D
J Bone Miner Res; 2007 Jan; 22(1):55-63. PubMed ID: 17014384
[TBL] [Abstract][Full Text] [Related]
19. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
Recker RR; Bare SP; Smith SY; Varela A; Miller MA; Morris SA; Fox J
Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]